Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

Interaction of Helicobacter pylori with genetic variants in the MDM2 promoter, is associated with gastric cancer susceptibility in Chinese patients.

Wang X, Yang J, Ho B, Yang Y, Huang Z, Zhang Z, Zhang G.

Helicobacter. 2009 Oct;14(5):114-9. doi: 10.1111/j.1523-5378.2009.00712.x.

PMID:
19751436
3.

Helicobacter pylori infection and MDM2 SNP309 association with gastric cancer susceptibility.

Moradi MT, Salehi Z, Asl SF, Aminian K, Hashtchin AR.

Genet Test Mol Biomarkers. 2013 Nov;17(11):794-8. doi: 10.1089/gtmb.2013.0173. Epub 2013 Sep 6.

PMID:
24010568
4.

MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.

Hirata H, Hinoda Y, Kikuno N, Kawamoto K, Suehiro Y, Tanaka Y, Dahiya R.

Clin Cancer Res. 2007 Jul 15;13(14):4123-9.

5.

Genetic Polymorphism of MDM2 SNP309 in Patients with Helicobacter Pylori-Associated Gastritis.

Tongtawee T, Dechsukhum C, Leeanansaksiri W, Kaewpitoon S, Kaewpitoon N, Loyd RA, Matrakool L, Panpimanmas S.

Asian Pac J Cancer Prev. 2015;16(16):7049-52.

6.

MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis.

Ma Y, Bian J, Cao H.

PLoS One. 2013;8(2):e56918. doi: 10.1371/journal.pone.0056918. Epub 2013 Feb 25.

7.

A functional SNP in the MDM2 promoter, pigmentary phenotypes, and risk of skin cancer.

Nan H, Qureshi AA, Hunter DJ, Han J.

Cancer Causes Control. 2009 Mar;20(2):171-9. doi: 10.1007/s10552-008-9231-9. Epub 2008 Sep 24.

8.

MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis.

Ohmiya N, Taguchi A, Mabuchi N, Itoh A, Hirooka Y, Niwa Y, Goto H.

J Clin Oncol. 2006 Sep 20;24(27):4434-40.

PMID:
16983111
9.

[Correlation of interleukin-10-1082G/a single nucleotide polymorphism to the risk of gastric cancer in north China: a case-control study].

Bai XL, Sun LP, Liu J, Chen W, Zhang Y, Yuan Y.

Ai Zheng. 2008 Jan;27(1):35-40. Chinese.

PMID:
18184461
10.

Polymorphisms in the MDM2 promoter and risk of breast cancer: a case-control analysis in a Chinese population.

Ma H, Hu Z, Zhai X, Wang S, Wang X, Qin J, Jin G, Liu J, Wang X, Wei Q, Shen H.

Cancer Lett. 2006 Aug 28;240(2):261-7. Epub 2005 Nov 8.

PMID:
16288830
11.

Involvement of p53 R72P polymorphism in the association of MDM2-SNP309 with breast cancer.

Leu JD, Wang CY, Tsai HY, Lin IF, Chen RC, Lee YJ.

Oncol Rep. 2011 Jun;25(6):1755-63. doi: 10.3892/or.2011.1254. Epub 2011 Apr 8.

PMID:
21479369
12.

Genetic polymorphisms of miR-146a and miR-27a, H. pylori infection, and risk of gastric lesions in a Chinese population.

Song MY, Su HJ, Zhang L, Ma JL, Li JY, Pan KF, You WC.

PLoS One. 2013 Apr 17;8(4):e61250. doi: 10.1371/journal.pone.0061250. Print 2013.

13.

MDM2 promoter SNP309 is associated with risk of occurrence and advanced lymph node metastasis of nasopharyngeal carcinoma in Chinese population.

Zhou G, Zhai Y, Cui Y, Zhang X, Dong X, Yang H, He Y, Yao K, Zhang H, Zhi L, Yuan X, Qiu W, Zhang X, Shen Y, Qiang B, He F.

Clin Cancer Res. 2007 May 1;13(9):2627-33.

14.
15.

MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL.

Dong HJ, Fang C, Fan L, Zhu DX, Wang DM, Zhu HY, Zhuang Y, Miao KR, Liu P, Xu W, Li JY.

Int J Cancer. 2012 May 1;130(9):2054-61. doi: 10.1002/ijc.26222. Epub 2011 Aug 9.

16.

MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis.

Wan Y, Wu W, Yin Z, Guan P, Zhou B.

BMC Cancer. 2011 May 29;11:208. doi: 10.1186/1471-2407-11-208.

17.

Analysis of the association of interleukin-17 gene polymorphisms with gastric cancer risk and interaction with Helicobacter pylori infection in a Chinese population.

Zhang X, Zheng L, Sun Y, Zhang X.

Tumour Biol. 2014 Feb;35(2):1575-80. doi: 10.1007/s13277-013-1217-x. Epub 2013 Nov 12.

PMID:
24218334
18.

Genetic variants in the MDM2 promoter and lung cancer risk in a Chinese population.

Hu Z, Ma H, Lu D, Qian J, Zhou J, Chen Y, Xu L, Wang X, Wei Q, Shen H.

Int J Cancer. 2006 Mar 1;118(5):1275-8.

19.

Association of breast cancer outcome with status of p53 and MDM2 SNP309.

Boersma BJ, Howe TM, Goodman JE, Yfantis HG, Lee DH, Chanock SJ, Ambs S.

J Natl Cancer Inst. 2006 Jul 5;98(13):911-9.

PMID:
16818855
20.

Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk.

Walsh CS, Miller CW, Karlan BY, Koeffler HP.

Gynecol Oncol. 2007 Mar;104(3):660-4. Epub 2006 Nov 21.

PMID:
17123590

Supplemental Content

Support Center